Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Keystone, Edward C.
348  Ergebnisse:
Personensuche X
?
1

Risk factors for prevalent and incident hypertension in rhe..:

Hadwen, Brook ; Stranges, Saverio ; Pope, Janet E...
Rheumatology Advances in Practice.  8 (2024)  2 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
2

Discontinuation of tofacitinib and TNF inhibitors in patien..:

Movahedi, Mohammad ; Choquette, Denis ; Coupal, Louis...
BMJ Open.  13 (2023)  3 - p. e063198 , 2023
Link: https://doi.org/10.1136/..
 
?
3

Safety and efficacy of filgotinib for Japanese patients wit..:

Tanaka, Yoshiya ; Matsubara, Tsukasa ; Atsumi, Tatsuya...
Modern Rheumatology.  33 (2022)  4 - p. 668-679 , 2022
Link: https://doi.org/10.1093/..
 
?
4

Effectiveness and Safety of Tofacitinib in Canadian Patient..:

Haraoui, Boulos ; Khraishi, Majed ; Choquette, Denis...
Arthritis Care & Research.  75 (2022)  2 - p. 240-251 , 2022
Link: https://doi.org/10.1002/..
 
?
5

Predictors of Influenza Vaccination in Early Rheumatoid Art..:

Ta, Viviane ; Schieir, Orit ; Valois, Marie‐France...
ACR Open Rheumatology.  4 (2022)  7 - p. 566-573 , 2022
Link: https://doi.org/10.1002/..
 
?
6

Statin Use for Primary Cardiovascular Disease Prevention Is..:

Kuriya, Bindee ; Akhtari, Shadi ; Movahedi, Mohammad...
Canadian Journal of Cardiology.  38 (2022)  8 - p. 1244-1252 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Efficacy and safety of tofacitinib modified-release 11 mg o..:

Cohen, Stanley B ; Pope, Janet ; Haraoui, Boulos...
RMD Open.  7 (2021)  2 - p. e001673 , 2021
Link: https://doi.org/10.1136/..
 
?
8

Efficacy of Long-Term Treatment with Once-Daily Baricitinib..:

Wells, Alvin F. ; Jia, Bochao ; Xie, Li...
Rheumatology and Therapy.  8 (2021)  2 - p. 987-1001 , 2021
Link: https://doi.org/10.1007/..
 
?
9

Primary and secondary non-response: in need of operational ..:

Vallejo-Yagüe, Enriqueta ; Keystone, Edward C ; Kandhasamy, Sreemanjari...
Annals of the Rheumatic Diseases.  80 (2021)  8 - p. 961-964 , 2021
Link: https://doi.org/10.1136/..
 
?
10

A Bridge Too Far? Real‐World Practice Patterns of Early Glu..:

Andersen, Kathleen M. ; Schieir, Orit ; Valois, Marie‐France...
ACR Open Rheumatology.  4 (2021)  1 - p. 57-64 , 2021
Link: https://doi.org/10.1002/..
 
?
11

Filgotinib versus placebo or adalimumab in patients with rh..:

Combe, Bernard ; Kivitz, Alan ; Tanaka, Yoshiya...
Annals of the Rheumatic Diseases.  80 (2021)  7 - p. 848-858 , 2021
Link: https://doi.org/10.1136/..
 
?
12

Efficacy and safety of filgotinib in combination with metho..:

Tanaka, Yoshiya ; Matsubara, Tsukasa ; Atsumi, Tatsuya...
Modern Rheumatology.  32 (2021)  2 - p. 263-272 , 2021
Link: https://doi.org/10.1093/..
 
?
13

Modified Disease Activity Score at 3 Months Is a Significan..:

Movahedi, Mohammad ; Weber, Deborah ; Akhavan, Pooneh.
ACR Open Rheumatology.  2 (2020)  3 - p. 188-194 , 2020
Link: https://doi.org/10.1002/..
 
?
14

Changes in selected haematological parameters associated wi..:

Kay, Jonathan ; Harigai, Masayoshi ; Rancourt, Josh...
RMD Open.  6 (2020)  3 - p. e001370 , 2020
Link: https://doi.org/10.1136/..
 
?
15

P210 Efficacy and safety of filgotinib for patients with RA..:

Nash, Peter ; Keystone, Edward C ; Bae, Sang-Cheol...
Rheumatology.  59 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
1-15